Global Liquid Biopsy Market - 2024-2033

September 2025 | 210 pages | ID: GD0BFC1F326CEN
DataM Intelligence

Abstracts

The Global Liquid Biopsy Market was valued at US$ 9.07 billion in 2024 and is anticipated to reach US$ 25.19 billion by 2033, at a CAGR of 0.107 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Global Liquid Biopsy Market.

This report delivers a comprehensive overview of the Global Liquid Biopsy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Liquid Biopsy Market. The Global Liquid Biopsy Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Global Liquid Biopsy Market Scope:

By Product Type

• Kits & Reagents
• Instruments
• Services

By Circulating Biomarker

• Circulating Tumor Cells
• Circulating Tumor DNA (ctDNA)
• Cell-free DNA (cfDNA)
• Extracellular Vesicles

By Application

• Cancer Applications
• Non-Cancer Applications

By Technology

• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

By End User

• Hospitals and Physician Laboratories
• Research Centers
• Others

Major Highlights

This report delivers a comprehensive overview of the Global Liquid Biopsy Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Liquid Biopsy Market. The Global Liquid Biopsy Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product Type
3.2. Snippet by Circulating Biomarker
3.3. Snippet by Application
3.4. Snippet by Technology
3.5. Snippet by End User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Prevalence of Cancer
    4.1.1.2. Rise in Customized Laser Surgery Based on Eye Biomechanics
    4.1.1.3. XX
  4.1.2. Restraints
    4.1.2.1. Standardization and Regulatory Challenges
    4.1.2.2. High Cost of Treatment Procedures
    4.1.2.3. XX
  4.1.3. Opportunity
    4.1.3.1. Expansion into Emerging Markets
    4.1.3.2. XX

5. IMPACT ANALYSIS

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established leaders with largest selling Brand
  6.1.3. Market leaders with established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
  6.5.1. North America
  6.5.2. Europe
  6.5.3. Asia Pacific
  6.5.4. Latin America
  6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Pipeline Analysis
6.8. Supply Chain Analysis
6.9. Patent Analysis
6.10. SWOT Analysis
6.11. Unmet Needs and Gaps
6.12. Recommended Strategies for Market Entry and Expansion
6.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.14. Pricing Analysis and Price Dynamics
6.15. Key Opinion Leaders

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  7.1.2. Market Attractiveness Index, By Product Type
7.2. Kits & Reagents*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Services

8. BY CIRCULATING BIOMARKER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  8.1.2. Market Attractiveness Index, By Circulating Biomarker
8.2. Circulating Tumor Cells*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Circulating Tumor DNA (ctDNA)
8.4. Cell-free DNA (cfDNA)
8.5. Extracellular Vesicles

9. BY APPLICATION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.1.2. Market Attractiveness Index, By Application
9.2. Cancer Applications*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Non-Cancer Applications

10. BY TECHNOLOGY

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.1.2. Market Attractiveness Index, By Technology
10.2. Multi-gene-parallel Analysis (NGS)*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Single Gene Analysis (PCR Microarrays)

11. BY END USER

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals and Physician Laboratories*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Research Centers
11.4. Others

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  12.1.2. Market Attractiveness Index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.2.8.1. U.S.
    12.2.8.2. Canada
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.3.8.1. Germany
    12.3.8.2. U.K.
    12.3.8.3. France
    12.3.8.4. Spain
    12.3.8.5. Italy
    12.3.8.6. Rest of Europe
12.4. Latin America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. Mexico
    12.4.8.2. Brazil
    12.4.8.3. Argentina
    12.4.8.4. Rest of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. China
    12.5.8.2. India
    12.5.8.3. Japan
    12.5.8.4. South Korea
    12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Circulating Biomarker
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

Key Market Players

1. EXOSOME SCIENCES INC*

1.1. Company Overview
  1.1.1. Product Portfolio
    1.1.1.1. Product Description
    1.1.1.2. Product Key Performance Indicators (KPIs)
    1.1.1.3. Historic and Forecasted Product Sales
    1.1.1.4. Product Sales Volume
  1.1.2. Financial Overview
    1.1.2.1. Company Revenue’s
    1.1.2.2. Geographical Revenue Shares
    1.1.2.3. Revenue Forecasts
  1.1.3. Key Developments
    1.1.3.1. Mergers & Acquisitions
    1.1.3.2. Key Product Development Activities
    1.1.3.3. Regulatory Approvals etc.
  1.1.4. SWOT Analysis
1.2. Illumina, Inc
1.3. Guardant Health
1.4. Thermo Fisher Scientific Inc
1.5. NeoGenomics Laboratories
1.6. Qiagen
1.7. BioChain Institute Inc
1.8. Sysmex Europe SE
1.9. Eurofins Genomics
1.10. Goffin Molecular Technologies
* Similar data will be provided for each market player.
Emerging Market Players

1. EXACT SCIENCES*

1.1. Pipeline Products Description
  1.1.1. Product Key Performance Indicators (KPIs)
  1.1.2. Key Activities
  1.1.3. Market Entry Timelines
  1.1.4. Product Penetration Rate
  1.1.5. Sales Estimation and Projections
1.2. Tempus
1.3. Dxcover Limited
* Similar data will be provided for each market player.
LIST NOT EXHAUSTIVE

1. APPENDIX

1.1. About Us and Services
1.2. Contact Us